PURPOSE: The anti-B-cell maturation antigen BiTE molecule AMG 420 was assessed in patients with relapsed/refractory multiple myeloma. PATIENTS AND METHODS: bone marrow cells by flow cytometry. RESULTS: Forty-two patients received AMG 420 at 0.2-800 μg/d. Median age was 65 years, and median disease d...
Highlights, strengths & weaknesses, commercial applications, and societal impact — written for this paper on demand.
No comments yet
Be the first to share your thoughts!